Literature DB >> 8258767

Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model.

S Björkman1, D R Stanski, H Harashima, R Dowrie, S R Harapat, D R Wada, W F Ebling.   

Abstract

Traditionally, physiological pharmacokinetic models assume that arterial blood flow to tissue is the rate-limiting step in the transfer of drug into tissue parenchyma. When this assumption is made the tissue can be described as a well-stirred single compartment. This study presents the tissue washout concentration curves of the two opioid analgesics fentanyl and alfentanil after simultaneous 1-min iv infusions in the rat and explores the feasibility of characterizing their tissue pharmacokinetics, modeling each of the 12 tissues separately, by means of either a one-compartment model or a unit disposition function. The tissue and blood concentrations of the two opioids were measured by gas-liquid chromatography. The well-stirred one-compartment tissue model could reasonably predict the concentration-time course of fentanyl in the heart, pancreas, testes, muscle, and fat, and of alfentanil in the brain and heart only. In most other tissues, the initial uptake of the opioids was considerably lower than predicted by this model. The unit disposition functions of the opioids in each tissue could be estimated by nonparametric numerical deconvolution, using the arterial concentration times tissue blood flow as the input and measured tissue concentrations as the response function. The observed zero-time intercepts of the unit disposition functions were below the theoretical value of one, and were invariably lower for alfentanil than for fentanyl. These findings can be explained by the existence of diffusion barriers within the tissues and they also indicate that alfentanil is less efficiently extracted by the tissue parenchyma than the more lipophilic compound fentanyl. The individual unit disposition functions obtained for fentanyl and alfentanil in 12 rat tissues provide a starting point for the development of models of intratissue kinetics of these opioids. These submodels can then be assembled into full physiological models of drug disposition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258767     DOI: 10.1007/bf01059779

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  21 in total

1.  Distribution of blood (Fe 59) and plasma (I 131) volumes of rats determined by liquid nitrogen freezing.

Authors:  N B EVERETT; B SIMMONS; E P LASHER
Journal:  Circ Res       Date:  1956-07       Impact factor: 17.367

Review 2.  An inequality-constrained least-squares deconvolution method.

Authors:  D Verotta
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

3.  Hemodynamic responses to alfentanil in halothane-anesthetized dogs.

Authors:  N D Kien; J A Reitan; D A White; C H Wu; J H Eisele
Journal:  Anesth Analg       Date:  1986-07       Impact factor: 5.108

4.  An extended physiological pharmacokinetic model of methadone disposition in the rat: validation and sensitivity analysis.

Authors:  J L Gabrielsson; T Groth
Journal:  J Pharmacokinet Biopharm       Date:  1988-04

5.  Multiple simultaneous determinations of hemodynamics and flow distribution in conscious rat.

Authors:  S F Flaim; S H Nellis; E J Toggart; H Drexler; K Kanda; E D Newman
Journal:  J Pharmacol Methods       Date:  1984-03

6.  Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation.

Authors:  J C Scott; D R Stanski
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

7.  Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats.

Authors:  S Björkman; D R Stanski; D Verotta; H Harashima
Journal:  Anesthesiology       Date:  1990-05       Impact factor: 7.892

8.  Effects of fentanyl on peripheral and cerebral hemodynamics in neonatal lambs.

Authors:  M Yaster; R C Koehler; R J Traystman
Journal:  Anesthesiology       Date:  1987-04       Impact factor: 7.892

9.  Understanding pharmacokinetics and pharmacodynamics through computer stimulation: I. The comparative clinical profiles of fentanyl and alfentanil.

Authors:  W F Ebling; E N Lee; D R Stanski
Journal:  Anesthesiology       Date:  1990-04       Impact factor: 7.892

10.  Analysis of pethidine disposition in the pregnant rat by means of a physiological flow model.

Authors:  J L Gabrielsson; P Johansson; U Bondesson; M Karlsson; L K Paalzow
Journal:  J Pharmacokinet Biopharm       Date:  1986-08
View more
  11 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

3.  Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratios.

Authors:  Ivelina Gueorguieva; Ivan A Nestorov; Susan Murby; Sophie Gisbert; Brent Collins; Kelly Dickens; Judith Duffy; Ziad Hussain; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-08       Impact factor: 2.745

4.  From piecewise to full physiologic pharmacokinetic modeling: applied to thiopental disposition in the rat.

Authors:  W F Ebling; D R Wada; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1994-08

5.  Physiologically based pharmacokinetic modeling of a homologous series of barbiturates in the rat: a sensitivity analysis.

Authors:  I A Nestorov; L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

6.  Tissue distribution kinetics as determinant of transit time dispersion of drugs in organs: application of a stochastic model to the rat hindlimb.

Authors:  M Weiss; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1996-04

7.  Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat.

Authors:  G E Blakey; I A Nestorov; P A Arundel; L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-06

8.  Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.

Authors:  Sven Björkman
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-08       Impact factor: 2.745

9.  Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles.

Authors:  Sheila Annie Peters
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models.

Authors:  S Björkman; D R Wada; D R Stanski; W F Ebling
Journal:  J Pharmacokinet Biopharm       Date:  1994-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.